12/1
Perelman School of Medicine
Could a single shot heal heart disease?
Experts at Penn Medicine are researching novel treatments for heart disease, including CRISPR gene editing technology, CAR T technology, and mRNA injections.
Lidocaine may be able to kill certain cancer cells by activating bitter taste receptors
A preclinical Penn Medicine study explains the previously observed anti-cancer effect of the common anesthetic drug.
A space for lifesaving, collaborative work
Gov. Josh Shapiro, President Liz Magill, and others from the University community celebrated the new home of the Penn Institute for RNA Innovation.
From high school to the hospital
An immersive program at the Perelman School of Medicine gives high school students a sneak peek at a potential future in the medical field.
New ‘patch’ uses natural body motion to fix disc herniation
The tension-activated repair patch plugs holes in discs in the spine like car tire patches, and could prevent further disease progression.
Pain scores, age can help identify patients more likely to use few or no opioids after surgery
A Penn Medicine study shows that patient pain scores are a good predictor for opioid use, but younger patients and those who hadn’t used opioids before are less likely to take them.
‘Give from the heart’: The final push for Penn’s annual workplace giving campaign
For this year’s campaign, ‘Going the Distance for our Community,’ Penn and Penn Medicine are matching faculty and staff contributions dollar for dollar in support of programs that directly benefit the community.
Decentralizing cancer screenings
A Projects for Progress team in the Abramson Cancer Center continues to work with the West Philadelphia community to bring cancer screenings out of clinical settings.
For pregnant people in states with most restrictive abortion policies, higher rates of cardiovascular complications
New research from Penn Medicine finds that states with tighter restraints on abortion may be tied to higher maternal morbidity and mortality, the effects of which may extend beyond pregnancy.
Penn Medicine studies unlock new insights into gene therapy
The studies on AAV-based gene therapies in non-human primates suggest that integration into human DNA is unlikely to drive cancer mutations.
In the News
More than 260,000 Penn Medicine patients have agreed to share their DNA for research, and the discoveries are just getting started
More than 260,000 people have signed up to participate in Penn Medicine BioBank, co-directed by Marilyn Ritchie and Dan Rader, which cross-references DNA with electronic health records to discover genetic variants of medical conditions.
FULL STORY →
New weight loss drugs carry high price tags and lots of questions for seniors
Mitchell Lazar of the Perelman School of Medicine says that weight loss drugs Ozempic and Wegovy have only been on the market for a few years and require caution.
FULL STORY →
Scientists find anesthetic kills cancer cells via unique mechanisms
A study led by Robert Lee of the Perelman School of Medicine found that the local anesthetic lidocaine targeted a receptor highly expressed across cancer cells.
FULL STORY →
Penn Medicine had a $58 million operating profit in summer quarter, up from $50 million last year
The University of Pennsylvania Health System reported a $58 million operating profit for the three months that ended Sept. 30., with remarks from Keith Kasper.
FULL STORY →
Is an Alzheimer’s blood test right for me?
Postdoc Claire Erickson and Emily Largent of the Perelman School of Medicine and the Leonard Davis Institute discuss which people should take an Alzheimer’s blood test.
FULL STORY →